Novo Holdings Warns US is Dominating European Biotech Research

Novo Holdings, a major investor, warns that the best European research in medicine and biotechnology is being acquired by American entities due to a lack of risk appetite among European investors and pension funds.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

berlingskeDanish58d ago

Novo-ejer advarer: USA snupper Europas guldæg

Den bedste forskning i Europa inden for medicin og bioteknologi lander på amerikanske hænder, fordi europæiske investorer og pensionskasser mangler risikovillighed.

Read full article →

Novo Holdings Warns US is Dominating European Biotech Research

Sources

Novo-ejer advarer: USA snupper Europas guldæg

Related Stories

Volkswagen Approves Major Restructuring Plan Involving 50,000 Job Cuts

US Diesel Prices Hit Record High Amid Supply Crises

Norway’s Sovereign Wealth Fund Proposes Major Cuts to U.S. Treasury Holdings

Lululemon Lowers Financial Outlook Again as Shares Drop